These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

71 related articles for article (PubMed ID: 890435)

  • 1. Plasma drug levels on once-daily dosage.
    Stevenson IH; Schiff AA
    Br Med J; 1977 Aug; 2(6086):579. PubMed ID: 890435
    [No Abstract]   [Full Text] [Related]  

  • 2. Sampling time, dosage schedule, and nortriptyline plasma levels.
    Ziegler VE; Knesevich JW; Wylie LT; Biggs JT
    Arch Gen Psychiatry; 1977 May; 34(5):613-5. PubMed ID: 871235
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Pharmacokinetic aspects on once-daily nortriptyline administration.
    Overø KF
    Neuropsychobiology; 1980; 6(1):34-41. PubMed ID: 7366812
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Once daily administration of a fluphenazine/nortriptyline preparation in the treatment of mixed anxiety/depressive states.
    Brodie NH; McGhie RL; O'Hara H; O'Hara J; Rodway AE; Valle-Jones JC; Schiff AA
    Curr Med Res Opin; 1976; 4(5):346-52. PubMed ID: 795608
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Implications of dose regimen and protein binding for plasma nortriptyline estimations.
    Stevenson IH; Wilson NM; Schiff AA
    Neuropharmacology; 1978 Jun; 17(6):423-6. PubMed ID: 673158
    [No Abstract]   [Full Text] [Related]  

  • 6. Once-daily treatment for mixed anxiety/depressive states: a comparison of slow release amitriptyline and fluphenazine with nortriptyline.
    Magnus RV; Schiff AA
    J Int Med Res; 1977; 5(2):109-13. PubMed ID: 873028
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Prediction of individual dosage of nortriptyline.
    Cooper TB; Simpson GM
    Am J Psychiatry; 1978 Mar; 135(3):333-5. PubMed ID: 626223
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Fluphenazine plasma levels and clinical response.
    Mavroidis ML; Kanter DR; Hirschowitz J; Garver DL
    J Clin Psychiatry; 1984 Sep; 45(9):370-3. PubMed ID: 6381472
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Plasma concentrations of amitriptyline during single nightly and thrice daily administration. Cross-over study.
    De Maio D; Drago F; Nielsen P; Ascalone V; Cisternino M
    Arzneimittelforschung; 1980; 30(2):335-7. PubMed ID: 7378116
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Preliminary data on the relationship between nortriptyline plasma level and response in depressed children.
    Geller B; Cooper TB; Chestnut EC; Anker JA; Schluchter MD
    Am J Psychiatry; 1986 Oct; 143(10):1283-6. PubMed ID: 3532829
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Fluphenazine plasma levels, dosage, efficacy, and side effects.
    Levinson DF; Simpson GM; Lo ES; Cooper TB; Singh H; Yadalam K; Stephanos MJ
    Am J Psychiatry; 1995 May; 152(5):765-71. PubMed ID: 7726317
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Gas chromatographic determination of amitriptyline, nortriptyline and perphenazine in plasma of schizophrenic patients after administration of the combination of amitriptyline with perphenazine.
    Cooper S; Albert JM; Dugal R; Bertrand M; Elie R
    Arzneimittelforschung; 1979; 29(1):158-61. PubMed ID: 582110
    [TBL] [Abstract][Full Text] [Related]  

  • 13. ECG changes during treatment with nortriptyline in a once-a-day dosage.
    Nielsen JL
    Neuropsychobiology; 1980; 6(1):48-51. PubMed ID: 7366814
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A comparison of amitriptyline and a fluphenazine/nortriptyline preparation in anxiety-depressive states.
    Bennie EH; Schiff AA
    Scott Med J; 1976 Oct; 21(4):204-9. PubMed ID: 793005
    [TBL] [Abstract][Full Text] [Related]  

  • 15. An evaluation of fluphenazine with nortriptyline in anxiety and depression.
    Anderson J; Lambert NG; Pigott PV
    Practitioner; 1972 Apr; 208(246):511-7. PubMed ID: 4555519
    [No Abstract]   [Full Text] [Related]  

  • 16. Inhibition of cytochrome P4502D6 activity with paroxetine normalizes the ultrarapid metabolizer phenotype as measured by nortriptyline pharmacokinetics and the debrisoquin test.
    Laine K; Tybring G; Härtter S; Andersson K; Svensson JO; Widén J; Bertilsson L
    Clin Pharmacol Ther; 2001 Oct; 70(4):327-35. PubMed ID: 11673748
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Treatment of unstable detrusor (irritable bladder) using fluphenazine and nortriptyline: progress report.
    Martin MR; James ED
    Prog Clin Biol Res; 1981; 78():335-8. PubMed ID: 7038710
    [No Abstract]   [Full Text] [Related]  

  • 18. Flupenthixol versus combined fluphenazine-nortriptyline in depressive illness.
    Conway JF
    Practitioner; 1981 Mar; 225(1353):400-4. PubMed ID: 7022433
    [No Abstract]   [Full Text] [Related]  

  • 19. Correlation of subjective side effects with plasma concentrations of nortriptyline.
    Asberg M; Cronholm B; Sjöqvist F; Tuck D
    Br Med J; 1970 Oct; 4(5726):18-21. PubMed ID: 5470429
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Clinical study with a combination of fluphenazine and nortriptyline in 70 cases of anxiety-depressive neuroses].
    Pacini L; Filippini G
    Clin Ter; 1977 May; 81(4):325-31. PubMed ID: 328219
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 4.